ARCA biopharma (NASDAQ:ABIO) Coverage Initiated by Analysts

StockNews.com initiated coverage on shares of ARCA biopharma (NASDAQ:ABIO – Get Rating) in a report released on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. ABIO stock opened at $2.33 on Friday. The stock has a market capitalization of $33.58 million, a PE ratio of -1.79 and a beta of 2.20. […]

Related Keywords

, Morgan Stanley , Geode Capital Management , Goldman Sachs Group Inc , Millennium Management , Dimensional Fund Advisors , Nasdaq , Fund Lp Funicular , Get Rating , Sachs Group , Capital Management , Recombinant Nematode Anticoagulant Protein , Arca Biopharma , Nasdaq Abio , Fabio , Medical , Initiated Coverage , Stocknews Com ,